Clinical Trials Directory

Trials / Terminated

TerminatedNCT04198168

The Predictive Performance of Renal Ultrasound on Changes in Renal Clearance

The Predictive Performance of Renal Ultrasonographic Perfusion Measures on Changes in Renal Clearance in Response to Fluid Therapy.

Status
Terminated
Phase
Study type
Observational
Enrollment
2 (actual)
Sponsor
Aarhus University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

The study will examine the ability of renal ultrasound (Doppler and Contrast Enhanced Ultrasound (CEUS)) in distinguishing ICU patients who exhibit increases in glomerular filtration rate (GFR) in response to fluid loading, from those for whom fluid loading is without benefit of directly harmful.

Detailed description

The study will examine the ability of renal ultrasound (Doppler and Contrast Enhanced Ultrasound (CEUS)) in distinguishing ICU patients who exhibit increases in GFR in response to fluid loading, from those for whom fluid loading is without benefit of directly harmful. Patients available for inclusion will receive a baseline administration of Tc-99-DTPA for precise determination of GFR/renal function by blood and urine samples. Baseline values of ultrasound measures will be obtained, including renal arterial, renal venous, portal venous and hepatic venous Doppler measures and renal contrast enhanced ultrasound (CEUS) will also be recorded. After two hours, baseline values of GFR are finished. The patient is then exposed to passive leg raising and ultrasound measures are repeated, including renal arterial, renal venous, portal venous and hepatic venous Doppler measures. The participant then receives a standardised fluid bolus of 7 ml/kg (ideal body weight) Once the fluid bolus administration is complete, renal ultrasound is repeated, including renal arterial, renal venous, portal venous, hepatic venous Doppler measures and renal CEUS. Follow-up determination of GFR/renal function based on Tc-99-DTPA after fluid therapy is repeated with blood and urine samples.

Conditions

Interventions

TypeNameDescription
DRUGIV crystalloid fluid bolusThe participant receives IV fluid as a standardised bolus of 7 ml/kg (ideal body weight).

Timeline

Start date
2020-01-01
Primary completion
2020-11-30
Completion
2020-11-30
First posted
2019-12-13
Last updated
2020-12-09

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT04198168. Inclusion in this directory is not an endorsement.